Applied synthetic chemistry has been placing increasing emphasis on stereochemistry. For many industries, especially pharmaceuticals, even minor structural differences between stereoisomers can significantly impact product performance. During the development of a drug candidate, scientists will produce many samples with increasing knowledge requirements about the configuration of the stereogenic centers within the common structure. There is a need to register the structural information associated with each sample accurately and precisely and to be able to retrieve related structures with their corresponding property data.
To this end, this white paper provides a detailed explanation of BIOVIA’s capabilities in stereochemical representation. The paper also suggests how scientists can best leverage these capabilities.